As the antibiotic pipeline produces new therapies, clinicians must understand each agent’s specific role in manage­ment of patients infected by multidrug-resistant pathogens.
THOMAS P. LODISE, PHARMD, PHD*
Advertisement
Articles by THOMAS P. LODISE, PHARMD, PHD*
Advertisement
Latest Updated Articles
- Two More Agents Bolster the Arsenal Against Gram-Negative Resistance
Published: December 12th 2019 | Updated:
Advertisement
Advertisement
Trending on Contagion Live
1
Global Collaboration and Immune-Based Innovation Take Center Stage in AMR Development
2
In A Matter of Months, MMR Vaccine Confidence Drops Significantly
3
Peggy Lillis Foundation Launches “See C diff” Campaign as National C diff Awareness Month Begins
4
FDA Approves IV Antbiotic, Contepo, for Complicated Urinary Tract Infections
5
